223 results on '"Sajjadi, Elham"'
Search Results
2. PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
3. HER2 Testing in Breast and Gastric Cancer with CDH1 Germline Mutations
4. NiO:Cu+2 mesoporous nanoparticles with enhanced oxidative sonophotocatalytic performance for visible-light driven organic pollutants remediation
5. Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study
6. Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
7. Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
8. Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients”
9. The evolving landscape of anatomic pathology
10. Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
11. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
12. Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients
13. Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
14. Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
15. NiO:Cu+2 mesoporous nanoparticles with enhanced oxidative sonophotocatalytic performance for visible-light driven organic pollutants remediation
16. Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
17. Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
18. Hereditary gastric and breast cancer syndromes with lung metastasis: narrative review of molecular and clinical insights
19. Trop-2 as an actionable biomarker in breast cancer
20. Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
21. Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
22. Characterization of the immune environment in pregnancy-associated breast cancer
23. Immune plasticity in pregnancy-associated breast cancer tumorigenesis
24. Computational pathology to improve biomarker testing in breast cancer: how close are we?
25. Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
26. The molecular landscape of breast mucoepidermoid carcinoma
27. Abstract P6-04-14: Comparison of next-generation sequencing and real-time PCR for PIK3CA testing in hormone receptor-positive/HER2-negative breast cancer on metastatic and matched primary tumor samples
28. Abstract P2-21-04: The tumor immune microenvironment composition and prognostic value in breast cancer during pregnancy is dynamic during the gestation period
29. An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
30. Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
31. The molecular landscape of breast mucoepidermoid carcinoma
32. An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
33. Determination of Mismatch Repair Status in Human Cancer and Its Clinical Significance: Does One Size Fit All?
34. Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances
35. Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
36. Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer
37. Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
38. Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
39. The evolving landscape of anatomic pathology
40. CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
41. HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
42. Abstract P4-10-23: Combined analysis of PTEN and routinely assessed biomarkers reveals new high-risk subgroups of HR- or HER2+ breast cancers
43. Abstract P3-18-08: Feasibility and safety of breast-conserving surgery in early-stage breast cancers during the first trimester of pregnancy
44. Abstract P4-10-15: Whole-body vibration combined with physical exercise to treat aromatase inhibitor-induced musculoskeletal symptoms in breast cancer women: Results of a pilot randomized controlled study
45. Abstract P4-07-02: Tumor microenvironment characteristics and prognosis in breast cancer during pregnancy: The role of differentially expressed immune-related genes
46. Abstract P4-07-01: Loss of HER2 on residual disease after neoadjuvant therapy in HER2-positive early breast cancer: Clinicopathological characteristics and association with outcomes
47. Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology
48. Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
49. A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast
50. Improving HER2 testing reproducibility in HER2-low breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.